Earnings call transcripts

Management framed the portfolio as reaching a self-funding inflection point, with substantial growth ahead but disciplined acquisition and capital-allocation priorities.

Management framed 2025 as a focused U.S. launch, with early account activation supporting confidence while reimbursement coding continues to mature.

Management framed IAM as the catalyst for modest acceleration, while emphasizing retention, enterprise expansion, and disciplined reinvestment over immediate double-digit growth.

Management framed the quarter as evidence that its commercial buildout and rental economics are beginning to scale, while emphasizing continued investment over near-term profitability.

Management framed 2026 around accelerating power demand, with coal services growth and the first large AI-campus contract underpinning a higher EBITDA target.

Management framed WW as an integrated weight-health platform gaining early traction from clinical offerings, while acknowledging execution remains early-stage.

Management framed 2025 as a shift toward a premium, brand-led training platform, with product mix and disciplined pricing supporting growth and margins.

Management framed 2026 as a restructuring year, with slower connected-home growth and persistent home-entertainment decline pushing cost cuts ahead of near-term revenue growth.

Management emphasized stronger-than-expected execution, accelerating Foot Locker tests, and back-half-weighted benefits despite investment and macro uncertainty.

Management framed 2025 as proof that its data-and-chemistry strategy can grow through a weak completion market, with PowerTech and recurring analytics driving the next phase.

Management framed 2026 as a year of disciplined commercial growth and pipeline milestones, while acknowledging near-term competition and regulatory uncertainty.

Management framed 2025 as the payoff from patient capacity-building and said demand now exceeds supply, with expansions positioned to unlock further growth.